# 64Cu-GRIP B in Patients With Acute Myocarditis

> **NCT07481136** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Javid Moslehi, MD** · enrollment: 10 (estimated)

## Conditions studied

- Acute Myocarditis

## Interventions

- **DRUG:** 64Cu-GRIP B is a radiolabeled peptide tracer, a copper-64 isotope bound to a peptide designed to target extracellular Granzyme B

## Key facts

- **NCT ID:** NCT07481136
- **Lead sponsor:** Javid Moslehi, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2030-11
- **Final completion:** 2031-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07481136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07481136, "64Cu-GRIP B in Patients With Acute Myocarditis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07481136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*